Boston Scientific’s chief financial officer believes the company has countered its critics by being successful with products that resulted from its 2006 takeover of device maker Guidant. Sam Leno told investors at a conference the deal has proven to be a growth engine for Boston Scientific. Five years from now, he said, the deal would be seen as one of the Boston Scientific’s most strategic acquisitions. New CEO Ray Elliott says he wants to diversify and expand the device maker’s presence in the areas of urology, gynecology and women’s health. (Click here for more)
“Buy or Sell—Is New CEO Reason To Buy Boston Scientific?” – Reuters (7/5/09)
Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com
